International Hernia Mesh Registry (IHMR)
This study is currently recruiting participants.
Verified April 2013 by Ethicon, Inc.
Sponsor:
Ethicon, Inc.
Information provided by (Responsible Party):
Ethicon, Inc.
ClinicalTrials.gov Identifier:
NCT00622583
First received: February 14, 2008
Last updated: April 25, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine patient reported long-term outcomes, and post-implantation clinical characteristics related to the use of mesh products in 3,500 patients minimum.
| Condition |
|---|
|
Hernia |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | A Two-Year Follow-up, Post-Implantation, Multi-center, International Hernia Mesh Registry |
Resource links provided by NLM:
Further study details as provided by Ethicon, Inc.:
Primary Outcome Measures:
- Recurrence of the hernia [ Time Frame: 1 month, 6-months, 12 months, 2 years ] [ Designated as safety issue: No ]
- Pain assessment scores by patients for the duration of the registry (Acute pain and Chronic pain) [ Time Frame: 1 month, 6-months, 12 months, 2 years ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Intraoperative handling characteristics for each ETHICON lightweight mesh product and all biologic mesh products [ Time Frame: At the time of surgery ] [ Designated as safety issue: No ]
- Assessment of post-operative complications/safety [ Time Frame: At the time of surgery ] [ Designated as safety issue: Yes ]
- Assessment of procedure time [ Time Frame: At the time of surgery ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 3500 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Observation Group
Subjects who meet the inclusion/exclusion criteria who have had a hernia repair.
|
Detailed Description:
To help identify best practices leading to lower recurrence rates and decreases in chronic pain associated with the hernia repair procedure.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Primary care clinic and patients of the investigators at local clinics or hospitals.
Criteria
Inclusion Criteria:
- Provide written informed consent;
- Male or female patients that are greater than or equal to 18 years of age
- Be literate and able to understand a language available in the Registry Patient Questionnaires;
- Be scheduled to receive a surgically implanted mesh product (synthetic or biologic) for repair of a hernia defect;
- Agree to provide long-term, outcomes data to Outcome Sciences, Inc;
- Agree to provide contact information.
Exclusion Criteria:
- Patients that are <18 years of age;
- Patients who have been entered into the registry previously;
- Employees of the investigator or registry center with direct involvement in the proposed registry or other studies under the direction of that investigator or registry center and employees of ETHICON;
- Patients suffering from and currently receiving medication for chronic pain;
- Patients known to be suffering from pre-existing chronic depression;
- Patients currently known or suspected to abuse drugs or alcohol;
- Patients suffering from a terminal illness (e.g. cancer);
- Patients requiring multiple hernia repairs utilizing more than one mesh or device, except bilateral inguinal or femoral, if operated on the same day. Two or more pieces of the same mesh product sewn together will be considered as one mesh, and is therefore allowed in this registry.
- Patients scheduled to receive both a synthetic and biologic mesh during the same procedure
- Patients requiring any other (concomitant) surgical procedure;
- Patients suffering from an ongoing infection.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00622583
Show 52 Study Locations
Contacts
| Contact: John Lombard | 908 218-2877 | jlombard8@its.jnj.com |
Show 52 Study LocationsSponsors and Collaborators
Ethicon, Inc.
Investigators
| Study Director: | Lynn McRoy, M.D. | Ethicon, Inc. |
More Information
No publications provided
| Responsible Party: | Ethicon, Inc. |
| ClinicalTrials.gov Identifier: | NCT00622583 History of Changes |
| Other Study ID Numbers: | 200-06-007 |
| Study First Received: | February 14, 2008 |
| Last Updated: | April 25, 2013 |
| Health Authority: | United States: Institutional Review Board Canada: Ethics Review Committee Italy: Ethics Committee Germany: Ethics Commission Netherlands: Independent Ethics Committee Australia: Human Research Ethics Committee Belgium: Institutional Review Board Spain: Ethics Committee United Kingdom: Research Ethics Committee France: Institutional Ethical Committee Sweden: Regional Ethical Review Board |
Keywords provided by Ethicon, Inc.:
|
Herniorrhaphy |
Additional relevant MeSH terms:
|
Hernia Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 22, 2013